News

Topline results from the CHASE trial expected by end of Q3 2025 -- -- Potential for CHASE to serve as a pivotal trial in support of a Biologics License Application (BLA) submission, contingent on ...
Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, ...
The Medipost CEO discusses developing treatments for knee osteoarthritis and other conditions.
The funding will support Gallant’s treatment for refractory feline chronic gingivostomatitis, which is in development.
For the first time, researchers have discovered and isolated adult stem cells from a non-human primate. This finding could ...
Accepted IND application allows for development program to move directly to a Phase 2 pivotal registration clinical trialPhase 2 clinical trial initiation anticipated in first half of 2026Pediatric ca ...
Investing.com -- Longeveron Inc. (NASDAQ: LGVN) stock surged 23% after the U.S. Food and Drug Administration approved the company’s Investigational New Drug (IND) application for laromestrocel, a ...
Mayo Clinic physician and researcher Dr. Abba Zubair's work combines two passions—medicine and space—for the benefit of ...
The autologous stem cell transplant program at Windsor Regional Hospital’s cancer centre will see patients’ own stem cells ...
New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...
Stem cell therapy has restored insulin production in about 10 patients with Type 1 diabetes, according to a study published ...